Impact of molecular pathology on the clinical management of lung cancer

Respiration. May-Jun 2005;72(3):229-32. doi: 10.1159/000085361.
No abstract available

Publication types

  • Editorial
  • Review
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / therapy
  • ErbB Receptors / genetics
  • Genetic Markers
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / therapy
  • Mutation / genetics
  • Prognosis
  • Proteomics / methods
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Genetic Markers
  • Tumor Suppressor Protein p53
  • ErbB Receptors